CA2271728A1 - Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents - Google Patents
Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents Download PDFInfo
- Publication number
- CA2271728A1 CA2271728A1 CA002271728A CA2271728A CA2271728A1 CA 2271728 A1 CA2271728 A1 CA 2271728A1 CA 002271728 A CA002271728 A CA 002271728A CA 2271728 A CA2271728 A CA 2271728A CA 2271728 A1 CA2271728 A1 CA 2271728A1
- Authority
- CA
- Canada
- Prior art keywords
- methyl
- carbon atoms
- triazin
- tetrahydro
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74887696A | 1996-11-14 | 1996-11-14 | |
US08/748,876 | 1996-11-14 | ||
PCT/US1997/020233 WO1998021190A1 (en) | 1996-11-14 | 1997-11-10 | Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2271728A1 true CA2271728A1 (en) | 1998-05-22 |
Family
ID=25011313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002271728A Abandoned CA2271728A1 (en) | 1996-11-14 | 1997-11-10 | Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0938480A1 (ja) |
JP (1) | JP2001503769A (ja) |
AR (1) | AR010068A1 (ja) |
AU (1) | AU5170698A (ja) |
CA (1) | CA2271728A1 (ja) |
WO (1) | WO1998021190A1 (ja) |
ZA (1) | ZA9710265B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562814B2 (en) | 2000-10-02 | 2003-05-13 | Wyeth | 3-thioxo-[1,2,4]-oxadiazinan-5-one derivatives |
CA2454059A1 (en) * | 2001-07-19 | 2003-01-30 | Cv Therapeutics, Inc. | Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK236878A (da) * | 1977-07-22 | 1979-01-23 | Pfizer | Tetrahydro-s-triazin-2(1h)-thioner |
HUT62558A (en) * | 1991-07-01 | 1993-05-28 | Sandoz Ag | Process for producing n-phenylthiourea derivaties and pharmaceutical compositions comprising same |
US5554607A (en) * | 1995-11-28 | 1996-09-10 | American Home Products Corporation | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis |
HUP9901968A3 (en) * | 1996-03-07 | 2000-01-28 | American Home Products Corp Ma | 2-thioxotetrahydropyrimidin-4-one derivatives and pharmaceutical compositions containing them |
-
1997
- 1997-11-10 EP EP97946555A patent/EP0938480A1/en not_active Withdrawn
- 1997-11-10 WO PCT/US1997/020233 patent/WO1998021190A1/en not_active Application Discontinuation
- 1997-11-10 JP JP52266598A patent/JP2001503769A/ja active Pending
- 1997-11-10 CA CA002271728A patent/CA2271728A1/en not_active Abandoned
- 1997-11-10 AU AU51706/98A patent/AU5170698A/en not_active Abandoned
- 1997-11-13 ZA ZA9710265A patent/ZA9710265B/xx unknown
- 1997-11-13 AR ARP970105309A patent/AR010068A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU5170698A (en) | 1998-06-03 |
EP0938480A1 (en) | 1999-09-01 |
WO1998021190A1 (en) | 1998-05-22 |
AR010068A1 (es) | 2000-05-17 |
JP2001503769A (ja) | 2001-03-21 |
ZA9710265B (en) | 1999-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5554607A (en) | Use of 2-thioxo-imidazolin-4-one derivatives in the treatment of atherosclerosis | |
JPH05331148A (ja) | カテコール誘導体、その薬学的に許容しうる塩およびエステルならびにそれらを含有する医薬組成物 | |
US5783707A (en) | 2-thioxo-imidazolidin-4-one derivatives | |
US4760078A (en) | Immunomodulator 1,2-dithiol-3-thione derivative composition, use method and process of producing the same | |
EP0876354A1 (en) | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives | |
US6160114A (en) | Substituted tetrahydro-1,3,5-triazin-2[1H]-thiones as anti-atherosclerotic agents | |
JPS6041655A (ja) | 尿素類およびチオ尿素類、それらの製造法並びに医薬用途 | |
CA2271728A1 (en) | Substituted tetrahydro-1,3,5-triazin-2[1h]-thiones as anti-atherosclerotic agents | |
WO1998057928A1 (en) | Elevation of hdl cholesterol by 2-(4-chloro -1-aryl-butylidene) -hydrazinecarbothioamides | |
US6008362A (en) | Elevation of HDL cholesterol by 2-(-4-chlorol-1-aryl-butylidene)-hydrazinecarbothioamides | |
WO1998057925A1 (en) | Elevation of hdl cholesterol by 2-[(aminothioxomethyl)-hydrazono]-2-arylethyl carbamates | |
JPS59116288A (ja) | ピラゾロ〔4.3−b〕〔1.4〕オキサジン類 | |
EP0876355A1 (en) | 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration | |
US5210097A (en) | Xanthocillin x monomethyl ether derivative and antitumor agent containing the same | |
US5807864A (en) | 2-thioxo-tetrahydropyrimidin-4-one derivatives | |
US6049006A (en) | Elevation of HDL cholesterol by N-[2-[(aminothioxomethyl) hydrazono]-2-arylethyl]amides | |
US6034272A (en) | Elevation of HDL cholesterol by N-[4-[(aminothioxomethyl) hydrazono]-4-arylbutyl]amides | |
US5599829A (en) | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives for increasing HDL cholesterol levels | |
US5663363A (en) | 2-thioxo-imidazolidin-4-one derivatives | |
US5821372A (en) | 2-thioxo-imidazolidin-4-one derivatives | |
US5861517A (en) | 2-thioxo-imidazolidin-4-one derivatives | |
US5939435A (en) | 2-substituted-1-acyl-1,2-dihydroquinoline derivatives | |
US6340687B1 (en) | Substituted tetrahydro-pyrimidine-2(1H)-thione HDL-C elevators useful as antiatherosclerotic agents | |
US5877324A (en) | 2-(substituted sulfanyl)-3,5-dihydro-imidazol-4-one derivatives | |
US6566375B1 (en) | Elevation of HDL cholesterol by 4-[(aminothioxomethyl)-hydrazono]-N-(substituted)-4-arylbutanamides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |